Clinical Trials
9 trialsNCT05063552 2026-06-03
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
National Cancer Institute (NCI)
Phase 2/3 Active not recruiting
NCT04508816 2022-04-04
Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy
Fudan University
Phase 2 Completed
NCT01230476 2019-10-07
Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma
University of Malaya
Phase 2 Terminated
NCT01326559 2017-08-16
Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
Hong Kong Nasopharyngeal Cancer Study Group Limited
Phase 2 Completed
NCT02633176 2015-12-17
Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT01712919 2014-03-24
Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)
Jiangsu Cancer Institute & Hospital
Phase 1/2 Completed
NCT01271439 2013-08-13
REPLACE
Sun Yat-sen University
Phase 2 Completed
NCT01614938 2012-06-08
Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
Fudan University
Phase 2 Unknown
NCT00700440 2010-03-26
ENCORE
Sun Yat-sen University
Phase 2 Completed